Robson, M. et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. New England Journal of Medicine; https://www.nejm.org/doi/10.1056/NEJMoa1706450 (2017).

Facebooktwitterlinkedininstagramflickrfoursquaremail